Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution — Class II drug recall D-0204-2024
Terminated recall by AnazaoHealth Corporation, reported 2024-01-03, distributed nationwide. Presence of Particulate Matter.
| Recall number | D-0204-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | AnazaoHealth Corporation, Las Vegas, NV, United States |
| Recall initiated | 2023-11-22 |
| Classified | 2023-12-26 |
| Reported by FDA | 2024-01-03 |
| Terminated | 2025-09-29 |
| Distributed | Nationwide (US) |
| Quantity | 3,363 vials |
| Reason classes | specification failure |
| NDC | 72682-8721-03 |
| Lot numbers | 508029, 513191, 524670, 526254, 530738, 533570, 538736, 543220, 543508, 545675 |
| Expiration dates | 2023-01-19, 2023-12-14, 2023-12-22, 2024-01-12, 2024-01-13, 2024-01-25, 2024-02-03, 2024-02-16, 2024-02-17, 2024-02-22 |
Product
Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, AnazaoHealth, 7465 W. Sunset Road, Las Vegas, NV, NDC 72682-8721-3.
Reason for recall
Presence of Particulate Matter.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0204-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.